347 related articles for article (PubMed ID: 18367491)
1. Cytoplasmic mutated nucleophosmin is stable in primary leukemic cells and in a xenotransplant model of NPMc+ acute myeloid leukemia in SCID mice.
Falini B; Martelli MP; Mecucci C; Liso A; Bolli N; Bigerna B; Pucciarini A; Pileri S; Meloni G; Martelli MF; Haferlach T; Schnittger S
Haematologica; 2008 May; 93(5):775-9. PubMed ID: 18367491
[TBL] [Abstract][Full Text] [Related]
2. Role of nucleophosmin in acute myeloid leukemia.
Meani N; Alcalay M
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1283-94. PubMed ID: 19761432
[TBL] [Abstract][Full Text] [Related]
3. Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype.
Luo J; Qi C; Xu W; Kamel-Reid S; Brandwein J; Chang H
Am J Clin Pathol; 2010 Jan; 133(1):34-40. PubMed ID: 20023256
[TBL] [Abstract][Full Text] [Related]
4. Cell line OCI/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin.
Quentmeier H; Martelli MP; Dirks WG; Bolli N; Liso A; Macleod RA; Nicoletti I; Mannucci R; Pucciarini A; Bigerna B; Martelli MF; Mecucci C; Drexler HG; Falini B
Leukemia; 2005 Oct; 19(10):1760-7. PubMed ID: 16079892
[TBL] [Abstract][Full Text] [Related]
5. Acute myeloid leukemia with mutated NPM1: diagnosis, prognosis and therapeutic perspectives.
Falini B; Sportoletti P; Martelli MP
Curr Opin Oncol; 2009 Nov; 21(6):573-81. PubMed ID: 19770764
[TBL] [Abstract][Full Text] [Related]
6. Acute myeloid leukemia with mutated nucleophosmin (NPM1): molecular, pathological, and clinical features.
Falini B
Cancer Treat Res; 2010; 145():149-68. PubMed ID: 20306250
[TBL] [Abstract][Full Text] [Related]
7. The leukemia-associated cytoplasmic nucleophosmin mutant is an oncogene with paradoxical functions: Arf inactivation and induction of cellular senescence.
Cheng K; Grisendi S; Clohessy JG; Majid S; Bernardi R; Sportoletti P; Pandolfi PP
Oncogene; 2007 Nov; 26(53):7391-400. PubMed ID: 17546053
[TBL] [Abstract][Full Text] [Related]
8. Altered nucleophosmin transport in acute myeloid leukaemia with mutated NPM1: molecular basis and clinical implications.
Falini B; Bolli N; Liso A; Martelli MP; Mannucci R; Pileri S; Nicoletti I
Leukemia; 2009 Oct; 23(10):1731-43. PubMed ID: 19516275
[TBL] [Abstract][Full Text] [Related]
9. NPM1 mutations and cytoplasmic nucleophosmin are mutually exclusive of recurrent genetic abnormalities: a comparative analysis of 2562 patients with acute myeloid leukemia.
Falini B; Mecucci C; Saglio G; Lo Coco F; Diverio D; Brown P; Pane F; Mancini M; Martelli MP; Pileri S; Haferlach T; Haferlach C; Schnittger S
Haematologica; 2008 Mar; 93(3):439-42. PubMed ID: 18268276
[TBL] [Abstract][Full Text] [Related]
10. Born to be exported: COOH-terminal nuclear export signals of different strength ensure cytoplasmic accumulation of nucleophosmin leukemic mutants.
Bolli N; Nicoletti I; De Marco MF; Bigerna B; Pucciarini A; Mannucci R; Martelli MP; Liso A; Mecucci C; Fabbiano F; Martelli MF; Henderson BR; Falini B
Cancer Res; 2007 Jul; 67(13):6230-7. PubMed ID: 17616680
[TBL] [Abstract][Full Text] [Related]
11. Cytoplasmic expression of nucleophosmin 1 as a marker for diagnosing residual disease of acute myeloid leukemia.
Dai Q; Ren Y
Appl Immunohistochem Mol Morphol; 2013 May; 21(3):205-11. PubMed ID: 23591014
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia with mutated nucleophosmin (NPM1): any hope for a targeted therapy?
Falini B; Gionfriddo I; Cecchetti F; Ballanti S; Pettirossi V; Martelli MP
Blood Rev; 2011 Nov; 25(6):247-54. PubMed ID: 21724308
[TBL] [Abstract][Full Text] [Related]
13. [Immunohistochemical demonstration of mutant nucleophosmin in acute myeloid leukemia: biological and clinical features related to NPMc expression].
Bedekovics J; Rejto L; Telek B; Udvardy M; Ujfalusi A; Oláh E; Hevessy Z; Kappelmayer J; Kajtár B; Méhes G
Orv Hetil; 2009 May; 150(22):1031-5. PubMed ID: 19465351
[TBL] [Abstract][Full Text] [Related]
14. A one-mutation mathematical model can explain the age incidence of acute myeloid leukemia with mutated nucleophosmin (NPM1).
Liso A; Castiglione F; Cappuccio A; Stracci F; Schlenk RF; Amadori S; Thiede C; Schnittger S; Valk PJ; Döhner K; Martelli MF; Schaich M; Krauter J; Ganser A; Martelli MP; Bolli N; Löwenberg B; Haferlach T; Ehninger G; Mandelli F; Döhner H; Michor F; Falini B
Haematologica; 2008 Aug; 93(8):1219-26. PubMed ID: 18603563
[TBL] [Abstract][Full Text] [Related]
15. Minimal residual disease detection in acute myeloid leukemia by mutant nucleophosmin (NPM1): comparison with WT1 gene expression.
Barragan E; Pajuelo JC; Ballester S; Fuster O; Cervera J; Moscardo F; Senent L; Such E; Sanz MA; Bolufer P
Clin Chim Acta; 2008 Sep; 395(1-2):120-3. PubMed ID: 18590714
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype.
Falini B; Mecucci C; Tiacci E; Alcalay M; Rosati R; Pasqualucci L; La Starza R; Diverio D; Colombo E; Santucci A; Bigerna B; Pacini R; Pucciarini A; Liso A; Vignetti M; Fazi P; Meani N; Pettirossi V; Saglio G; Mandelli F; Lo-Coco F; Pelicci PG; Martelli MF;
N Engl J Med; 2005 Jan; 352(3):254-66. PubMed ID: 15659725
[TBL] [Abstract][Full Text] [Related]
17. The cytoplasmic NPM mutant induces myeloproliferation in a transgenic mouse model.
Cheng K; Sportoletti P; Ito K; Clohessy JG; Teruya-Feldstein J; Kutok JL; Pandolfi PP
Blood; 2010 Apr; 115(16):3341-5. PubMed ID: 19666870
[TBL] [Abstract][Full Text] [Related]
18. Mutated nucleophosmin detects clonal multilineage involvement in acute myeloid leukemia: Impact on WHO classification.
Pasqualucci L; Liso A; Martelli MP; Bolli N; Pacini R; Tabarrini A; Carini M; Bigerna B; Pucciarini A; Mannucci R; Nicoletti I; Tiacci E; Meloni G; Specchia G; Cantore N; Di Raimondo F; Pileri S; Mecucci C; Mandelli F; Martelli MF; Falini B
Blood; 2006 Dec; 108(13):4146-55. PubMed ID: 16926285
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia.
Falini B; Martelli MP; Bolli N; Bonasso R; Ghia E; Pallotta MT; Diverio D; Nicoletti I; Pacini R; Tabarrini A; Galletti BV; Mannucci R; Roti G; Rosati R; Specchia G; Liso A; Tiacci E; Alcalay M; Luzi L; Volorio S; Bernard L; Guarini A; Amadori S; Mandelli F; Pane F; Lo-Coco F; Saglio G; Pelicci PG; Martelli MF; Mecucci C
Blood; 2006 Sep; 108(6):1999-2005. PubMed ID: 16720834
[TBL] [Abstract][Full Text] [Related]
20. Acute myeloid leukemia carrying cytoplasmic/mutated nucleophosmin (NPMc+ AML): biologic and clinical features.
Falini B; Nicoletti I; Martelli MF; Mecucci C
Blood; 2007 Feb; 109(3):874-85. PubMed ID: 17008539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
